BeStock  
Stocks › Biotechnology › HRMY

Harmony Biosciences HRMY

US equityMarket cap rank #2704Biotechnology
$32.59 −$0.39 (-1.18%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $32.59 0.00%
Open$32.68
Prev close$32.98
Day range$32.51 – $33.43
Volume582.6K
Market cap$1.91B
P/E (TTM)10.8
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$268.92M+12.3% YoY
Operating profit$54.20M-17.2% YoY
Net profit$48.20M-5.2% YoY
Diluted EPS$0.81-6.9% YoY
Free cash flow$76.69M-29.4% YoY
Operating cash flow$76.69M

Revenue, last 8 quarters

$201.3MDec '24$184.7MMar '25$200.5MJun '25$239.5MSep '25$243.8MDec '25$215.4MMar '26$261.3MJun '26$268.9MSep '26

Net profit, last 8 quarters

$49.5MDec '24$45.6MMar '25$39.8MJun '25$50.9MSep '25$22.5MDec '25$32.5MMar '26$75.4MJun '26$48.2MSep '26

Diluted EPS by quarter

0.85Dec '240.78Mar '250.68Jun '250.87Sep '250.38Dec '250.55Mar '261.28Jun '260.81Sep '26

Free cash flow by quarter

$75.0MDec '24$33.9MMar '25$79.3MJun '25$108.7MSep '25$126.0MDec '25$27.8MMar '26$92.4MJun '26$76.7MSep '26

Annual revenue

$159.7MFY20$305.4MFY21$437.9MFY22$582.0MFY23$714.7MFY24$868.5MFY25

Profitability & balance sheet

Gross margin74.0%
Operating margin22.2%
Net margin18.1%
Return on equity18.7%
Return on assets13.3%
Return on invested capital15.1%
Current ratio3.44
Liabilities / assets27.5%
Cash & investments$771.14M
Total debt$149.10M
Net cash (debt)$622.03M
Free cash flow / sales32.6%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $268.92M $261.28M $215.39M $868.45M $243.78M
Total Operating Revenue $268.92M $261.28M $215.39M $868.45M $243.78M
Cost of Revenue $80.69M $63.20M $44.51M $198.34M $68.55M
Gross Profit $188.23M $198.08M $170.88M $670.11M $175.23M
Operating Expense $134.03M $108.77M $133.58M $461.64M $136.67M
Selling and Admin Expenses $62.37M $62.17M $64.20M $272.05M $86.74M
-Selling & Marketing Expense $34.72M $34.12M $31.69M $119.51M $29.18M
-General & Admin Expense $27.65M $28.05M $32.51M $152.54M $57.56M
Research & Development $71.66M $46.60M $69.38M $189.59M $49.93M
Operating Profit $54.20M $89.32M $37.29M $208.47M $38.56M
Net Non-Operating Interest Income (Expense) $5.37M $4.00M $2.52M $7.28M $2.31M
Non-Operating Interest Income $8.43M $7.07M $5.76M $21.92M $5.85M
Non-Operating Interest Expense $3.06M $3.07M $3.23M $14.65M $3.55M
Other Income (Expense) -$316,000.00 -$53,000.00 -$127,000.00 -$680,000.00 -$105,000.00
Other Non-Operating Income (Expenses) -$316,000.00 -$53,000.00 -$127,000.00 -$680,000.00 -$105,000.00
Pretax Profit $59.25M $93.27M $39.69M $215.06M $40.76M
Tax $11.05M $17.83M $7.20M $56.38M $18.27M
Net Profit $48.20M $75.43M $32.49M $158.69M $22.49M
Profit from Continuing Operations $48.20M $75.43M $32.49M $158.69M $22.49M
Net Income to Parent Company $48.20M $75.43M $32.49M $158.69M $22.49M
Net Income to Common Stockholders $48.20M $75.43M $32.49M $158.69M $22.49M
Basic EPS $0.83 $1.30 $0.56 $2.76 $0.39
Diluted EPS $0.81 $1.28 $0.55 $2.71 $0.38
Special Income (Charges) – – – $0.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.48B $1.37B $1.27B $1.27B $1.27B
Total Current Assets $934.83M $814.33M $778.82M $907.01M $907.01M
Cash and Cash Equivalents & Short-Term Investments $771.14M $667.79M $640.92M $775.34M $775.34M
-Cash and Cash Equivalents $647.10M $549.77M $589.40M $752.50M $752.50M
-Short Term Investments $124.04M $118.02M $51.52M $22.84M $22.84M
Receivables $127.74M $111.00M $108.22M $96.79M $96.79M
-Accounts Receivable $127.74M $111.00M $108.22M $96.79M $96.79M
Prepaid Assets $18.10M $19.31M $16.80M $16.01M $16.01M
Inventory $5.87M $6.36M $5.28M $5.36M $5.36M
Other Current Assets $11.98M $9.88M $7.60M $13.52M $13.52M
Total Non-Current Assets $543.42M $558.75M $493.01M $364.62M $364.62M
Investments and Advances $280.47M $294.67M $229.56M $107.13M $107.13M
-Available for Sale Securities $280.47M $294.67M $229.56M $107.13M $107.13M
Goodwill and Other Intangible Assets $71.54M $77.50M $83.46M $89.42M $89.42M
Non-Current Deferred Assets $161.37M $156.77M $153.56M $149.70M $149.70M
Other Non-Current Assets $30.05M $29.82M $26.43M $18.37M $18.37M
Total Liabilities $406.01M $373.84M $361.48M $401.41M $401.41M
Total Current Liabilities $271.54M $234.07M $217.34M $252.13M $252.13M
Payables $26.92M $21.68M $28.60M $17.69M $17.69M
-Accounts Payable $26.92M $21.68M $28.60M $17.69M $17.69M
Current Accrued Expenses $208.06M $169.13M $150.11M $191.04M $191.04M
Short-Term Debt and Capital Lease Obligation $20.00M $20.00M $20.00M $20.00M $20.00M
-Current Debt $20.00M $20.00M $20.00M $20.00M $20.00M
Other Current Liabilities $1.68M $11.17M $11.91M $4.96M $4.96M
Total Non-Current Liabilities $134.47M $139.77M $144.14M $149.28M $149.28M
Long Term Debt and Capital Lease Obligation $129.10M $133.96M $138.81M $143.66M $143.66M
-Long Term Debt $129.10M $133.96M $138.81M $143.66M $143.66M
Other Non-Current Liabilities $5.37M $5.81M $5.32M $5.62M $5.62M
Total Equity $1.07B $999.24M $910.35M $870.22M $870.22M
Stockholders' Equity $1.07B $999.24M $910.35M $870.22M $870.22M
Capital Stock $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00
-Common Stock $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00
Additional Paid-In Capital $757.15M $731.15M $717.37M $708.97M $708.97M
Retained Earnings $317.02M $268.82M $193.39M $160.90M $160.90M
Gains/Losses Not Affecting Retained Earnings -$1.94M -$727,000.00 -$413,000.00 $346,000.00 $346,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $76.69M $92.43M $27.76M $348.20M $126.15M
Net cash flow from continuing operations $76.69M $92.43M $27.76M $348.20M $126.15M
Net Income from Continuing Operations $48.20M $75.43M $32.49M $158.69M $22.49M
Depreciation & Depletion & Amortization $5.97M $5.97M $5.97M $25.34M $7.43M
Deferred Tax -$4.60M -$3.20M -$3.86M -$7.30M $7.38M
Other Non-Cash Items $25.76M $1.07M $32.40M $36.29M $5.13M
Change in Working Capital -$5.96M $4.25M -$49.63M $91.82M $74.04M
-Change in Receivables -$16.74M -$2.77M -$11.44M -$13.75M $3.86M
-Change in Inventory $489,000.00 -$1.08M $76,000.00 $1.84M $1.53M
-Change in Prepaid Assets -$1.54M -$7.85M -$3.00M $31.79M $24.85M
-Change in Payables and Accrued Expense $5.24M -$6.92M $10.91M $3.95M -$8.65M
-Change in Other Current Liabilities $6.60M $22.87M -$46.18M $67.99M $52.45M
Net cash flow from investing $7.68M -$131.50M -$183.65M -$39.65M -$17.63M
Net Cash Flow from Continuing Investing Activities $7.68M -$131.50M -$183.65M -$39.65M -$17.63M
Net PPE Purchase and Sale $0.00 $0.00 $0.00 -$310,000.00 -$107,000.00
Net Investment Purchase and Sale $7.68M -$131.50M -$151.65M -$5.09M $1.72M
Net Other Investing Changes $0.00 $0.00 -$32.00M -$15.00M $0.00
Financing Cash Flow $12.96M -$558,000.00 -$7.22M -$9.05M -$3.02M
Net Cash Flow from Continuing Financing Activities $12.96M -$558,000.00 -$7.22M -$9.05M -$3.02M
Net Issuance Payments Of Debt -$5.00M -$5.00M -$5.00M -$16.25M -$5.00M
Proceeds from Stock Option Exercised $17.96M $5.52M $347,000.00 $10.21M $2.65M
Net Other Financing Charges $0.00 -$1.08M -$2.57M -$3.00M -$663,000.00
Ending Cash Balance $647.37M $550.04M $589.67M $752.77M $752.77M
Net Change in Cash $97.33M -$39.63M -$163.10M $299.50M $105.50M
Beginning Cash Balance $550.04M $589.67M $752.77M $453.27M $647.27M
Free Cash Flow $76.69M $92.43M $27.76M $347.89M $126.04M
Net Business Purchase and Sale – – – -$19.25M -$19.25M
Net Common Stock Issuance – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on HRMY.

Sign in to join the discussion.

Scroll to Top